Invention Grant
US07550465B2 Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
失效
吡啶并[3,2-e]吡嗪,它们用作磷酸二酯酶10的抑制剂,以及它们的制备方法
- Patent Title: Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
- Patent Title (中): 吡啶并[3,2-e]吡嗪,它们用作磷酸二酯酶10的抑制剂,以及它们的制备方法
-
Application No.: US11753207Application Date: 2007-05-24
-
Publication No.: US07550465B2Publication Date: 2009-06-23
- Inventor: Norbert Höfgen , Hans Stange , Barbara Langen , Ute Egerland , Rudolf Schindler , Thomas Pfeifer , Chris Rundfeldt
- Applicant: Norbert Höfgen , Hans Stange , Barbara Langen , Ute Egerland , Rudolf Schindler , Thomas Pfeifer , Chris Rundfeldt
- Applicant Address: DE Radebeul
- Assignee: Elbion GmbH
- Current Assignee: Elbion GmbH
- Current Assignee Address: DE Radebeul
- Agency: Fulbright & Jaworski L.L.P.
- Main IPC: A61K31/4985
- IPC: A61K31/4985
![Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them](/abs-image/US/2009/06/23/US07550465B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to pyrido[3,2-e]pyrazines, to processes for preparing them, to pharmaceutical preparations which comprise these compounds and to the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 10, as active compounds for treating diseases of mammals including a human which can be influenced by using the compounds according to the invention to inhibit phosphodiesterase 10 activity in the central nervous system. More particularly, the invention relates to the treatment of neurologic and psychiatric disorders, for example psychosis and disorders comprising cognitive deficits as symptoms.
Public/Granted literature
Information query
IPC分类: